The prognostic significance of cytogenetic aberrations in childhood acute myeloid leukaemia. A study of the Swiss Paediatric Oncology Group (SPOG)

European Journal of Haematology

Volumn 78, Issue 6, 2007, Pages 468-476

  Betts, David R ^a   Ammann, Roland A ^b   Hirt, Andreas ^b   Hengartner, Heinz ^c   Beck Popovic, Maja ^d   Kuhne, Thomas ^e   Nobile, Luisa ^f   Caflisch, Ueli ^g   Wacker, Pierre ^h   Niggli, Felix K ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c Children's Hospital St Gallen   (Switzerland)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^f Children's Hospital   (Switzerland)

^g CHILDREN S HOSPITAL   (Switzerland)

^h Hopital des Enfants Hopitaux universitaires de Geneve   (Switzerland)

Author keywords

Acute myeloid leukaemia; Child; Cytogenetics

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME 11Q; CHROMOSOME 16Q; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION 11; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SWITZERLAND;

ACUTE DISEASE; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INCIDENCE; KARYOTYPING; LEUKEMIA, MYELOID; MALE; PROGNOSIS; REMISSION INDUCTION; SURVIVAL ANALYSIS;

EID: 34248547644     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00854.x     Document Type: Article

References (32)

1. Creutzig U, Zimmermann M, Ritter J, et al. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. Leukemia 2005 19 : 2030 42.
2. Entz-Werle N, Suciu S, van der Werff ten Bosch J, et al. Results of 58872 and 58921 trials in acute myeloblastic leukemia and relative value of chemotherapy vs allogeneic bone marrow transplantation in first complete remission: the EORTC Children Leukemia Group report. Leukemia 2005 19 : 2072 81.
3. Gibson BES, Wheatley K, Hann IM, Stevens RF, Webb D, Hills RK, De Graaf SSN, Harrison CJ, for the United Kingdom Childhood Leukaemia Working Party, the Dutch Childhood Oncology Group. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia 2005 19 : 2130 8.
4. Kardos G, Zwaan CM, Kaspers GJL, et al. Treatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trials. Leukemia 2005 19 : 2063 71.
5. Lie SO, Abrahamsson J, Clausen N, et al. Long-term results in children with AML: NOPHO-AML Study Group - report of three consecutive trials. Leukemia 2005 19 : 2090 100.
6. Perel Y, Auvrignon A, Leblanc T, et al. Treatment of childhood acute myeloblastic leukemia: dose intensification improves outcome and maintenance therapy is of no benefit - multicenter studies of the French LAME (Leucémie Aiguë Myéloblastique Enfant) Cooperative Group. Leukemia 2005 19 : 2082 9.
7. Pession A, Rondelli R, Basso G, Rizzari C, Testi AM, Fagioli F, De Stefano P, Locatelli F, and on behalf of the AML Strategy Study Committee of the Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP). Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocols. Leukemia 2005 19 : 2043 53.
8. Ravindranath Y, Chang M, Steuber CP, et al. Pediatric Oncology Group (POG) studies of acute myeloid leukemia (AML): a review of four consecutive childhood AML trials conducted between 1981 and 2000. Leukemia 2005 19 : 2101 16.
9. Ribeiro RC, Razzouk BI, Pounds S, Hijiya N, Pui C-H, Rubnitz JE. Successive clinical trials for childhood acute myeloid leukemia at St Jude Children's Research Hospital, from 1980 to 2000. Leukemia 2005 19 : 2125 9.
10. Smith FO, Alonzo TA, Gerbing RB, Woods WG, Arceci RJ, for the Children's Cancer Group. Long-term results of children with acute myeloid leukemia: a report of three consecutive Phase III trials by the Children's Cancer Group: CCG 251, CCG 213 and CCG 2891. Leukemia 2005 19 : 2054 62.
11. Bloomfield CD, Shuma C, Regal L, et al. Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International Workshop on Chromosomes in Leukemia. Cancer 1997 80 : 2191 8.
12. Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. Blood 1998 92 : 2322 33.
13. Byrd JC, Mrózek K, Dodge RK, et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002 100 : 4325 36.
14. Martinez-Climent JA, Lane NJ, Rubin CM, et al. Clinical and prognostic significance of chromosomal abnormalities in childhood acute myeloid leukemia de novo. Leukemia 1995 9 : 95 101.
15. Raimondi SC, Chang MN, Ravindranath Y, Behm FG, Gresik MV, Steuber CP, Weinstein JH, Carroll AJ, for the Pediatric Oncology Group. Chromosomal abnormalities in 478 children with acute myeloid leukemia: clinical characteristics and treatment outcome in a Cooperative Pediatric Oncology Group Study - POG 8821. Blood 1999 94 : 3707 16.
16. Forestier E, Heim S, Blennow E, et al. Cytogenetic abnormalities in childhood acute myeloid leukaemia: a Nordic series comprising all children enrolled in the NOPHO-93-AML trial between 1993 and 2001. Brit J Haematol 2003 121 : 566 77.
17. Stark B, Jeison M, Gabay LG, et al. Classical and molecular cytogenetic abnormalities and outcome of childhood acute myeloid leukaemia: report from a referral centre in Israel. Brit J Haematol 2004 126 : 320 37.
18. Kong XT, Ida K, Ichikawa H, et al. Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript. Blood 1997 90 : 1192 9.
19. Lam DH, Aplan PD. NUP98 gene fusions in hematologic malignancies. Leukemia 2001 15 : 1689 95.
20. Ma Z, Morris SW, Valentine V, et al. Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia. Nature Genet 2001 28 : 220 1.
21. Shaffer LG, Tommerup N, eds. ISCN 2005. An International System for Cytogenetic Nomenclature. Basel : S Karger.
22. Therneau TM, Grambsch PM. Modeling Survival Data. New York : Springer, 2000.
23. Visani G, Bernasconi P, Boni M, et al. The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia-analysis of 848 patients. Leukemia 2001 15 : 903 9.
24. Wells RJ, Arthur DC, Srivastava A, et al. Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213. Leukemia 2002 16 : 601 7.
25. Hann IM, Webb DK, Gibson BE, Harrison CJ. MRC trials in childhood acute myeloid leukaemia. Ann Hematol 2004 83 : 108 12.
26. Kardos G, Baumann I, Passmore SJ, et al. Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. Blood 2003 102 : 1997 2003.
27. Sandoval C, Head DR, Mirro J Jr., Behm FG, Ayers GD, Raimondi SC. Translocation t(9;11)(p21;q23) in pediatric de novo and secondary acute myeloblastic leukemia. Leukemia 1992 6 : 513 9.
28. Mrozek K, Heinonen K, Lawrence D, et al. Adult patients with de novo acute myeloid leukemia and t(9;11)(p22;q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study. Blood 1997 90 : 4532 8.
29. Kondo M, Horibe K, Takahashi Y, Matsumoto K, Fukuda M, Inaba J, Kato K, Kojima S, Matsuyama T. Prognostic value of internal tandem duplication of the FLT3 gene in childhood acute myelogenous leukemia. Med Pediatr Oncol 1999 33 : 525 9.
30. Bienz M, Ludwig M, Leibundgut EO, Mueller BU, Ratschiller D, Solenthaler M, Fey MF, Pabst T. Risk assessment in patients with acute myeloid leukemia and a normal karyotype. Clin Cancer Res 2005 11 : 1416 24.
31. Meshinchi S, Woods WG, Stirewalt DL, Sweetser DA, Buckley JD, Tjoa TK, Bernstein ID, Radich JP. Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia. Blood 2001 97 : 89 94.
32. Zwaan CM, Meshinchi S, Radich JP, et al. FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance. Blood 2003 102 : 2387 94.